Home » Authors » Christopher Delporte

Articles by Christopher Delporte

FDA panel recommends Gore's TAG for thoracic aneurysms

Jan. 18, 2005

By Christopher Delporte

Liver disease and diagnostics targeted by NIH action plan

Jan. 13, 2005

By Christopher Delporte

Washington roundup: Malpractice reform is low on public's healthcare to-do list

Jan. 12, 2005

By Christopher Delporte

Liver disease and diagnostics targeted by NIH action plan

Jan. 11, 2005

By Christopher Delporte

Bush using 'capital' to push malpractice reform legislation

Jan. 10, 2005

By Christopher Delporte

Personal health records need role of federal government

Jan. 6, 2005

By Christopher Delporte

NIH Roadmap reports progress toward 'new ways of thinking'

Dec. 1, 2004

By Christopher Delporte

Schultz settling into his perceived role as CDRH problem solver

Dec. 1, 2004

By Christopher Delporte

No lack of innovation in device sector, says CDRH chief Schultz

Nov. 1, 2004

By Christopher Delporte

Diabetic patients benefit from DES technology, study shows

Nov. 1, 2004

By Christopher Delporte

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...